Navin Fluorine International
- P/E
- 57.03
Key Fundamentals
MidcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 21.00%
- Debt to Equity
- 0.32
- EPS (TTM)
- ₹154.05
- Book Value
- ₹869.60
- Market Cap
- —
- P/E (TTM)
- 57.03
- P/B
- 10.10
- ROE
- 19.60%
- Dividend Yield
- 0.09%
- EBITDA
- ₹1,147 Cr
- 52W High
- ₹8,949.50
- 52W Low
- ₹5,440.00
- Day Range
- ₹8,515.50 – ₹8,813.00
- Volume
- 1,97,042
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| Navin Fluorine International (this company) | ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| Median 7 companies | ₹1,578.40 | 57.03 | ₹20,919 Cr | 6.04 | 0.23% | 9.82% | 11.90% | ₹6,969 Cr | ₹784 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 66
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 27
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 99
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 63
- Good
- Solvency, leverage, coverage 9% weight
- Momentum
- 90
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 46
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is expected to give good quarter
- Company has delivered good profit growth of 21.4% CAGR over last 5 years
Weaknesses
1- Stock is trading at 10.7 times its book value
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 3 | 4 | 12 |
| Oscillators | Bearish | 3 | 4 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 59.33
- Neutral
- MACD (12,26,9)
- 50.71
- Bullish
- SMA (50)
- 8,400.00
- Bullish
- SMA (200)
- 7,270.21
- Bullish
As of
Analyst Rating
20 of 27 analysts rate Buy, 3 Hold, 4 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +17.16% |
|---|---|
| 5Y | +22.96% |
| 3Y | +16.85% |
| 1Y | +41.08% |
| TTM | +42.41% |
Net profit
| 10Y | +22.97% |
|---|---|
| 5Y | +20.81% |
| 3Y | +20.98% |
| 1Y | +129.76% |
| TTM | +122.25% |
Operating cash flow
| 10Y | +27.95% |
|---|---|
| 5Y | +30.41% |
| 3Y | Turned positive |
| 1Y | +56.57% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +15.30 pp |
|---|---|
| 5Y | +6.44 pp |
| 3Y | +6.17 pp |
| 1Y | +9.92 pp |
| TTM | +8.82 pp |
Revenue by year
| Mar 2017 | ₹742 Cr |
|---|---|
| Mar 2018 | ₹913 Cr |
| Mar 2019 | ₹996 Cr |
| Mar 2020 | ₹1,062 Cr |
| Mar 2021 | ₹1,179 Cr |
| Mar 2022 | ₹1,453 Cr |
| Mar 2023 | ₹2,077 Cr |
| Mar 2024 | ₹2,065 Cr |
| Mar 2025 | ₹2,349 Cr |
| Mar 2026 | ₹3,314 Cr |
Net profit by year
| Mar 2017 | ₹137 Cr |
|---|---|
| Mar 2018 | ₹180 Cr |
| Mar 2019 | ₹149 Cr |
| Mar 2020 | ₹409 Cr |
| Mar 2021 | ₹258 Cr |
| Mar 2022 | ₹263 Cr |
| Mar 2023 | ₹375 Cr |
| Mar 2024 | ₹270 Cr |
| Mar 2025 | ₹289 Cr |
| Mar 2026 | ₹664 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Navin Fluorine International Ltd trades at ₹8,680 as of 2026-10-30 with a market cap of ₹44,522 Cr. The company has delivered TTM sales growth of 42% and TTM profit growth of 124%, but trades at a P/E of 56.35x and 11.21x book value, reflecting rich valuations relative to its specialty chemicals peer set.
- TTM profit growth of 124% signals a sharp earnings recovery, with EPS at ₹154.05 on a trailing basis
- TTM revenue growth of 42% significantly outpaces the 10-year compounded sales CAGR of 17%, indicating an acceleration in top-line momentum
- 5-year compounded profit CAGR of 21% demonstrates consistent earnings compounding over a meaningful period
- Last-year ROE of 20% is the highest in the reported series, improving from the 3-year average of 14% and 5-year average of 15%
- ROCE of 18.66% indicates efficient capital deployment and healthy return generation on total capital employed
- Debt-to-equity ratio of 0.32 reflects a conservatively leveraged balance sheet, providing capacity for future capex funding
- Stock has delivered a 1-year return of 81%, sharply outperforming the broader market, with 52-week range of ₹5,428–₹8,950 showing strong upward trajectory
- 10-year stock CAGR of 33% and 10-year compounded profit CAGR of 23% reflect a long track record of wealth creation and earnings growth
- P/E of 56.35x on TTM earnings is significantly elevated, leaving limited room for execution misses or earnings disappointments
- Price-to-book of 11.21x is extremely rich even for a specialty chemicals company, pricing in substantial future growth
- Dividend yield of just 0.18% offers negligible income return, making the stock almost entirely dependent on capital appreciation
- Stock trades at ₹8,680, just 3% below its 52-week high of ₹8,950, raising the risk of mean-reversion or consolidation at current levels
- 3-year compounded sales CAGR of 17% is materially lower than TTM growth of 42%, raising questions about whether the current growth rate is sustainable or one-off
- 3-year ROE of 14% is notably lower than the last-year figure of 20%, suggesting the recent profitability spike may not yet be proven as a structural shift
- 5-year stock CAGR of 16% is modest compared to the 1-year return of 81%, indicating that much of the recent re-rating has been compressed into a short period
- At a market cap of ₹44,522 Cr, the stock carries a premium valuation that assumes flawless execution on capacity expansion and new contract wins in the fluorine value chain
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Navin Fluorine delivered a strong Q1FY27 with PAT doubling and revenue up 44%, led by CDMO and specialty chemicals momentum. No visible headwinds in recent news flow. The upcoming analyst meet on Oct 12 could offer further clarity on order pipeline and capacity utilization. The near-term trend appears firmly positive.
- Q1FY27 profit surges 108% YoY Sep 30
Navin Fluorine reported Q1FY27 PAT of ₹243 crore, up 108% YoY. Revenue grew 44% to ₹1,045 crore, driven by strong CDMO and specialty segments.
- Analyst meet scheduled Oct 12 Sep 30
Navin Fluorine has scheduled a meeting with analysts and investors on October 12, which could provide forward guidance and segment-level commentary.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 491 | 472 | 500 | 602 | 524 | 519 | 606 | 701 | 725 | 758 | 892 | 938 | 1,045 | 1,191 |
| Expenses | 377 | 373 | 424 | 492 | 423 | 411 | 459 | 522 | 519 | 512 | 585 | 617 | 688 | 783 |
| Operating Profit | 114 | 98 | 76 | 110 | 100 | 107 | 147 | 179 | 207 | 246 | 308 | 321 | 357 | 407 |
| OPM % | 23% | 21% | 15% | 18% | 19% | 21% | 24% | 26% | 29% | 32% | 34% | 34% | 34% | 34% |
| Other Income | 8 | 23 | 64 | 13 | 10 | 11 | 10 | 12 | 14 | 18 | −5 | 31 | 35 | 16 |
| Interest | 19 | 20 | 18 | 17 | 16 | 14 | 20 | 28 | 30 | 30 | 28 | 29 | 32 | 29 |
| Depreciation | 21 | 24 | 25 | 26 | 27 | 28 | 30 | 35 | 35 | 37 | 36 | 41 | 42 | 43 |
| PBT | 82 | 77 | 97 | 79 | 68 | 77 | 108 | 127 | 155 | 198 | 238 | 282 | 318 | 352 |
| Tax % | 25% | 22% | 20% | 11% | 25% | 23% | 23% | 25% | 24% | 25% | 22% | 25% | 24% | 23% |
| Net Profit | 62 | 61 | 78 | 70 | 51 | 59 | 84 | 95 | 117 | 148 | 185 | 213 | 243 | 269 |
| EPS (₹) | 12.41 | 12.22 | 15.74 | 14.19 | 10.32 | 11.86 | 16.86 | 19.15 | 23.62 | 28.96 | 36.18 | 41.48 | 47.43 | — |
Sep 2026: from the results filed on 30 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 592 | 680 | 742 | 913 | 996 | 1,062 | 1,179 | 1,453 | 2,077 | 2,065 | 2,349 | 3,314 | 3,634 |
| Expenses | 519 | 561 | 582 | 693 | 777 | 794 | 870 | 1,098 | 1,527 | 1,666 | 1,816 | 2,232 | 2,402 |
| Operating Profit | 72 | 118 | 159 | 220 | 219 | 268 | 309 | 356 | 550 | 399 | 534 | 1,082 | 1,232 |
| OPM % | 12% | 17% | 21% | 24% | 22% | 25% | 26% | 24% | 26% | 19% | 23% | 33% | 34% |
| Other Income | 29 | 23 | 55 | 88 | 34 | 29 | 94 | 38 | 36 | 107 | 44 | 58 | 80 |
| Interest | 3 | 4 | 3 | 1 | 1 | 2 | 2 | 2 | 28 | 75 | 78 | 118 | 120 |
| Depreciation | 20 | 22 | 30 | 40 | 28 | 37 | 44 | 48 | 63 | 96 | 119 | 149 | 156 |
| PBT | 78 | 116 | 182 | 266 | 224 | 258 | 358 | 344 | 496 | 336 | 380 | 873 | 1,036 |
| Tax % | 26% | 28% | 25% | 32% | 34% | −56% | 31% | 24% | 24% | 19% | 24% | 24% | — |
| Net Profit | 58 | 84 | 137 | 180 | 149 | 409 | 258 | 263 | 375 | 270 | 289 | 664 | 790 |
| EPS (₹) | 11.18 | 17.08 | 27.88 | 36.43 | 30.15 | 82.57 | 52.02 | 53.09 | 75.68 | 54.56 | 58.19 | 129 | 154 |
| Div. Payout % | 29% | 25% | 23% | 27% | 26% | 13% | 21% | 21% | 16% | 27% | 12% | 7% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 578 | 636 | 825 | 974 | 1,063 | 1,402 | 1,624 | 1,834 | 2,175 | 2,373 | 2,616 | 3,964 |
| Borrowings | 61 | 82 | 19 | 13 | 4 | 1 | 25 | 121 | 861 | 1,368 | 1,466 | 1,272 |
| Other Liabilities | 203 | 228 | 324 | 259 | 231 | 215 | 239 | 420 | 484 | 626 | 738 | 1,133 |
| Total Liabilities | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 6,379 |
| Fixed Assets | 274 | 375 | 561 | 428 | 430 | 529 | 540 | 556 | 1,646 | 1,875 | 2,736 | 3,324 |
| CWIP | 60 | 20 | 17 | 20 | 39 | 39 | 95 | 742 | 279 | 711 | 355 | 143 |
| Investments | 171 | 170 | 239 | 428 | 427 | 195 | 99 | 118 | 44 | 495 | 480 | 1,229 |
| Other Assets | 346 | 390 | 360 | 380 | 410 | 866 | 1,163 | 969 | 1,561 | 1,296 | 1,259 | 1,683 |
| Total Assets | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 6,379 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1 | 76 | 92 | 169 | 90 | 157 | 237 | 75 | −64 | 750 | 571 | 894 |
| Investing | 3 | −53 | −16 | −136 | −24 | 85 | −237 | −172 | −656 | −1,094 | −511 | −1,235 |
| Financing | −21 | −17 | −67 | −39 | −68 | −81 | −45 | 42 | 658 | 336 | −47 | 344 |
| Net Cash Flow | −17 | 6 | 10 | −6 | −3 | 161 | −45 | −56 | −61 | −8 | 13 | 3 |
| Free Cash Flow | −61 | 58 | −84 | 121 | 29 | 59 | 147 | −501 | −819 | 72 | 4 | 404 |
| CFO/OP | 28 | 87 | 78 | 100 | 74 | 76 | 71 | 43 | 8 | 196 | 122 | 97 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 81 | 68 | 62 | 63 | 75 | 88 | 90 | 99 | 91 | 90 | 83 |
| Inventory Days | 96 | 89 | 136 | 110 | 91 | 127 | 129 | 149 | 197 | 150 | 117 | 121 |
| Days Payable | 113 | 112 | 94 | 92 | 58 | 79 | 77 | 85 | 103 | 122 | 118 | 144 |
| Cash Conversion Cycle | 57 | 57 | 110 | 80 | 96 | 123 | 140 | 154 | 193 | 119 | 89 | 60 |
| Working Capital Days | 39 | 37 | 4 | 43 | 58 | 88 | 113 | 109 | 140 | 45 | 25 | 44 |
| ROCE % | 11% | 17% | 22% | 29% | 21% | 21% | 22% | 19% | 20% | 11% | 11% | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Navin Fluorine International insights
70 extracted metrics across FY11–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · May 2026Transcript PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- 13 Aug 2026
- 11 Sep 2025
- 9 Oct 2024
- 7 Nov 2023
- 10 Jan 2023
- Newspaper Advertisement Of The Financial Results For The Quarter & Half Year Ended September 30 2026General announcements 31 Oct 2026
- General announcements 30 Oct 2026
Frequently Asked Questions about Navin Fluorine International
What does Navin Fluorine International Ltd do?
Where is Navin Fluorine International Ltd (NAVINFLUOR) listed?
Which sector does Navin Fluorine International Ltd belong to?
What is the PE ratio of Navin Fluorine International Ltd?
What is the 52-week high and low of Navin Fluorine International Ltd?
Does Navin Fluorine International Ltd pay dividends?
What is the Return on Equity (ROE) of Navin Fluorine International Ltd?
Company Information
Navin Fluorine International Ltd is primary engaged in producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers contract research and manufacturing services. Its portfolio includes 50+ fluorinated compounds developed over the years.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NAVINFLUOR.md for Navin Fluorine International Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.